NantHealth Inc

NantHealth Inc

NH - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$10.4M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
NantHealth IncNantHealth Inc0-28%0.2-0.4
$1.60

Current Fair Value

18.9% upside

Undervalued by 18.9% based on the discounted cash flow analysis.

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$10.40 Million
Enterprise Value$105.05 Million
Earnings per Share$-8.8
Beta1.82
Outstanding Shares7,703,304

Return

Return on Equity28.13%ROE
Return on Assets-48.04%
Return on Invested Capital99.62%

Valuation & Multiples

P/E Ratio0P/E Ratio
PEG-0.01PEG
Price to Sales0.17Price to Sales
Price to Book Ratio-0.04Price to Book Ratio
Enterprise Value to Revenue1.63
Enterprise Value to EBIT-2.36
Enterprise Value to Net Income-2
Total Debt to Enterprise0.96
Debt to Equity-0.4Debt to Equity

Revenue Sources

No data

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About NantHealth, Inc.

365 employees
CEO: Rao Haris Naseem FACC,

NantHealth, Inc., together with its subsidiaries, operates as a healthcare IT company in the United States, Canada, and the United Kingdom. It offers Eviti, a software-as-a-service (SaaS) based clinical decision support solution that cen...

NantHealth Insider Information FAQ

In the latest 13F quarter on Stockcircle, 3 top investors reduced or sold among tracked top investors. Changes are based on reported share counts in their quarterly filings, not day-to-day trading.

Form 4 insider trades are added as new filings are imported. Top investor 13F holdings refresh after each quarterly filing cycle. Politician trade disclosures are added when new reports are published on Stockcircle.